Gynecologic Oncology-Indiana - IN Marion, Indianapolis 46237

Gynecologic Oncology-Indiana entered the industry of Oncologists in 2007 and has grown to employ 1 to 4 people, generating an annual revenue of $500.000 to $999.999. The NAICS classifies this business under the code 6211110, which describes it as a Oncologists. For further clarification, the SIC classifies this business under the code 8011 and described it as a Oncologists. The business provides service to the B2C market.

To acquire more information, please contact April Vande Voort, Office Manager by calling (317) 851-2555 during business hours. You can also write to the business’ Single Location at 8111 South Emerson Avenue, Indianapolis, Indiana IN 46237. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .

Company: Gynecologic Oncology-Indiana
Representative: April Vande Voort, Office Manager
Place of Business: 8111 South Emerson Avenue, Indianapolis, IN 46237
Contact Number: (317) 851-2555
Type of Service: Oncologists
SIC Number: 8011
NAICS Number: 6211110
Locality: Single Location
Market Type: B2C (Business to Consumer)
Began: 2007
Income/Year: $500.000 to $999.999
Laborers: 1 to 4
Share This Company:

Gynecologic Oncology-Indiana is a company operating from Marion, Indiana providing professional Oncologists and relevant B2C variables. It was founded in 2007 and registered with the SIC code 8011 as Oncologists, and with the NAICS code 6211110 as Oncologists.

With a current employee count of 1 to 4, Gynecologic Oncology-Indiana has gone to report making $500.000 to $999.999 per annum on its journey towards growth. This company invites you to contact its representative April Vande Voort, Office Manager at (317) 851-2555 for related queries, or to locate its Single Location using the coordinates 39.650131,-86.082579.

The Single Location can also be found at the street address 8111 South Emerson Avenue in Indianapolis, Indiana 46237 and can be engaged online through the company website at , the company Twitter , and Facebook page .